Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2003 3
2004 4
2005 1
2006 5
2007 3
2008 2
2009 3
2010 2
2011 4
2012 2
2013 5
2014 5
2015 4
2016 7
2017 6
2018 7
2019 7
2020 6
2021 3
2022 6
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Overview of influenza viruses.
Pleschka S. Pleschka S. Curr Top Microbiol Immunol. 2013;370:1-20. doi: 10.1007/82_2012_272. Curr Top Microbiol Immunol. 2013. PMID: 23124938 Review.
Itaconate and derivatives reduce interferon responses and inflammation in influenza A virus infection.
Sohail A, Iqbal AA, Sahini N, Chen F, Tantawy M, Waqas SFH, Winterhoff M, Ebensen T, Schultz K, Geffers R, Schughart K, Preusse M, Shehata M, Bähre H, Pils MC, Guzman CA, Mostafa A, Pleschka S, Falk C, Michelucci A, Pessler F. Sohail A, et al. Among authors: pleschka s. PLoS Pathog. 2022 Jan 13;18(1):e1010219. doi: 10.1371/journal.ppat.1010219. eCollection 2022 Jan. PLoS Pathog. 2022. PMID: 35025971 Free PMC article.
NRF2 activators inhibit influenza A virus replication by interfering with nucleo-cytoplasmic export of viral RNPs in an NRF2-independent manner.
Waqas FH, Shehata M, Elgaher WAM, Lacour A, Kurmasheva N, Begnini F, Kiib AE, Dahlmann J, Chen C, Pavlou A, Poulsen TB, Merkert S, Martin U, Olmer R, Olagnier D, Hirsch AKH, Pleschka S, Pessler F. Waqas FH, et al. Among authors: pleschka s. PLoS Pathog. 2023 Jul 17;19(7):e1011506. doi: 10.1371/journal.ppat.1011506. eCollection 2023 Jul. PLoS Pathog. 2023. PMID: 37459366 Free PMC article.
Influenza H3N2 Vaccines: Recent Challenges.
Mostafa A, Pleschka S. Mostafa A, et al. Among authors: pleschka s. Trends Microbiol. 2018 Feb;26(2):87-89. doi: 10.1016/j.tim.2017.12.003. Trends Microbiol. 2018. PMID: 29268980
Phenotypic effects of mutations observed in the neuraminidase of human origin H5N1 influenza A viruses.
Scheibner D, Salaheldin AH, Bagato O, Zaeck LM, Mostafa A, Blohm U, Müller C, Eweas AF, Franzke K, Karger A, Schäfer A, Gischke M, Hoffmann D, Lerolle S, Li X, Abd El-Hamid HS, Veits J, Breithaupt A, Boons GJ, Matrosovich M, Finke S, Pleschka S, Mettenleiter TC, de Vries RP, Abdelwhab EM. Scheibner D, et al. Among authors: pleschka s. PLoS Pathog. 2023 Feb 6;19(2):e1011135. doi: 10.1371/journal.ppat.1011135. eCollection 2023 Feb. PLoS Pathog. 2023. PMID: 36745654 Free PMC article.
90 results